Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|May 23, 2012
Ipilimumab-induced colitis on FDG PET/CTAshima Lyall, Herbert Alberto Vargas, Richard D Carvajal, et al.
Clinical Transplantation|May 6, 2026
Cancer in Organ Recipients With Metastatic Spread to Transplant Organs: A Systematic ReviewClaire Ma, Fiona McIntosh, Sungmin Woo, et al.
Urologic Oncology|November 9, 2021
Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survivalSungmin Woo, Soleen Ghafoor, Jeeban P Das, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance imagesDuc Fehr, Harini Veeraraghavan, Andreas Wibmer, et al.
Insights Into Imaging|March 5, 2019
How clinical imaging can assess cancer biologyRoberto García-Figueiras, Sandra Baleato-González, Anwar R Padhani, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 29, 2019
Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?Publio Cesar Cavalcanti Viana, Natally Horvat, Valter Ribeiro do Santos, et al.
Cancers|November 20, 2020
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian CarcinomaHarini Veeraraghavan, Herbert Alberto Vargas, Alejandro Jimenez-Sanchez, et al.
NPJ Precision Oncology|February 14, 2024
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapyCharlotte S Walmsley, Philip Jonsson, Michael L Cheng, et al.
European Radiology|November 30, 2021
Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working GroupAtul B Shinagare, Elizabeth A Sadowski, Hyesun Park, et al.
Pageof 1